Clincosm LogoSign in Get a demo

crohn's disease

Showing 26 - 50 of 644
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Crohn's Disease Trial in Japan (E6011 2 mg/kg, E6011 5 mg/kg, E6011 10 mg/kg)

Completed
Has Results
  • Crohn's Disease
  • E6011 2 mg/kg
  • +3 more
  • Nagoya, Aichi, Japan
  • +16 more
Apr 28, 2022

Crohn's Disease, Complex Perianal Fistula Trial in Worldwide (Darvadstrocel)

Active, not recruiting
  • Crohn's Disease
  • Complex Perianal Fistula
  • Darvadstrocel
  • San Francisco, California
  • +77 more
Jan 18, 2023

Crohn's Disease Trial in Worldwide (Mirikizumab)

Recruiting
  • Crohn's Disease
  • Dothan, Alabama
  • +318 more
Jan 18, 2023

Vedolizumab and Biologic Agents in Inflammatory Bowel Disease

Completed
  • Inflammatory Bowel Disease (IBD)
  • +2 more
    • Taichung, Taiwan
    • +3 more
    Jan 18, 2023

    Crohn's Disease Trial (Intermittent caloric restriction)

    Not yet recruiting
    • Crohn's Disease
    • Intermittent caloric restriction
    • (no location specified)
    Jan 4, 2023

    Subcutaneous HUMIRA Injection to Assess Adverse Events and

    Recruiting
    • Crohn's Disease
      • Beijing, Beijing, China
      • +8 more
      Jan 12, 2023

      Crohn's Disease, IBD Trial in Worldwide (Brazikumab Induction Dose, Brazikumab Maintenance Dose)

      Enrolling by invitation
      • Crohn's Disease
      • IBD
      • Brazikumab Induction Dose
      • Brazikumab Maintenance Dose
      • Lincoln, California
      • +116 more
      Jan 12, 2023

      Crohn's Disease Trial in Edmonton (Synbiotic, Digestible Maltodextrin)

      Recruiting
      • Crohn's Disease
      • Synbiotic
      • Digestible Maltodextrin
      • Edmonton, Alberta, Canada
      • +4 more
      Jan 10, 2023

      Biologics or Small Molecule Therapies in Inflammatory Bowel

      Completed
      • Crohn's Disease
      • Ulcerative Colitis
        • New York, New York
        • +1 more
        Jan 9, 2023

        Ulcerative Colitis, Ulcerative Colitis Chronic, IBD Trial in Worldwide (Mirikizumab)

        Recruiting
        • Ulcerative Colitis
        • +3 more
        • San Francisco, California
        • +15 more
        Dec 26, 2022

        Crohn's Disease, Ulcerative Colitis Trial in Montpellier (Immuno monitoring)

        Completed
        • Crohn's Disease
        • Ulcerative Colitis
        • Immuno monitoring
        • Montpellier, France
          University hospital
        Dec 13, 2022

        Crohn's Disease Trial in Warszawa (CT-P13 SC (Infliximab), Placebo SC)

        Active, not recruiting
        • Crohn's Disease
        • CT-P13 SC (Infliximab)
        • Placebo SC
        • Warszawa, Poland
          WIP Warsaw IBD Point Profesor Kierkus
        Dec 6, 2022

        A Survey of Darvadstrocel in People With Crohn's Disease

        Recruiting
        • Crohn's Disease
        • Darvadstrocel
        • Tokyo, Japan
          Takeda selected site
        Dec 5, 2022

        Crohn's Disease Trial in Canada, United States (Alicaforsen)

        Completed
        • Crohn's Disease
        • Little Rock, Arkansas
        • +29 more
        Dec 1, 2022

        Inflammatory Bowel Disease Receiving Vedolizumab in Patient

        Not yet recruiting
        • Ulcerative Colitis
        • Crohn's Disease
        • No Intervention
        • (no location specified)
        Nov 28, 2022

        Perianal Fistula, Crohn's Disease Trial (Human TH-SC01 cell injection)

        Not yet recruiting
        • Perianal Fistula
        • Crohn's Disease
        • Human TH-SC01 cell injection
        • (no location specified)
        Nov 15, 2022

        Crohn's Disease Trial in Parkville (PillCam® COLON 2 Capsule Endoscopy)

        Completed
        • Crohn's Disease
        • PillCam® COLON 2 Capsule Endoscopy
        • Parkville, Victoria, Australia
          Royal Melbourne Hospital
        Nov 21, 2022

        Crohn's Disease Trial in United States (CDPATH™, Blood Draw)

        Recruiting
        • Crohn's Disease
        • CDPATH™
        • Blood Draw
        • Phoenix, Arizona
        • +54 more
        Nov 10, 2022

        Ulcerative Colitis (UC), Crohn's Disease Trial in Germany, Israel, United States (Risankizumab, Cytochrome P450 (CYP)

        Completed
        • Ulcerative Colitis (UC)
        • Crohn's Disease
        • Coronado, California
        • +5 more
        Oct 20, 2022

        Participants Receiving Flixabi or Imraldi: a French Cohort Study

        Completed
        • Arthritis, Rheumatoid
        • +4 more
        • Caluire et Cuire, Auvergne-Rhône-Alpes, France
        • +59 more
        Oct 17, 2022

        Pouchitis, Crohn's Disease, Ulcerative Colitis Chronic Trial in Cleveland (Mesenchymal Stem Cells (MSCs))

        Withdrawn
        • Pouchitis
        • +4 more
        • Mesenchymal Stem Cells (MSCs)
        • Cleveland, Ohio
          Cleveland Clinic
        Oct 10, 2022

        Perianal Fistula, Crohn's Disease Trial in United States (Seton Placement, AVB-114)

        Recruiting
        • Perianal Fistula
        • Crohn's Disease
        • Scottsdale, Arizona
        • +4 more
        Oct 3, 2022

        Crohn's Disease Trial in Bulgaria, Poland, United States (BT-11 1,000 mg, Placebo)

        Completed
        • Crohn's Disease
        • BT-11 1,000 mg
        • Placebo
        • Huntsville, Alabama
        • +26 more
        Sep 20, 2022

        Ulcerative Colitis or Crohn's Disease Receiving Vedolizumab in

        Recruiting
        • Inflammatory Bowel Disease (IBD)
        • +2 more
          • Wroclaw, Dolnoslskie, Poland
          • +10 more
          Sep 12, 2022

          Crohn's Disease, Glycogen Metabolism, Inflammatory Bowel Disease (IBD) Trial run by the National Institute of Allergy and

          Recruiting
          • Crohn's Disease
          • +2 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Aug 20, 2022